These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2726283)

  • 1. Reductions of body weight and blood pressure in obese hypertensive patients treated by diet. A retrospective study.
    Novi RF; Porta M; Lamberto M; Molinatti GM
    Panminerva Med; 1989; 31(1):13-5. PubMed ID: 2726283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Weight reduction and blood pressure].
    Greminger P; Studer A; Lüscher T; Mutter B; Grimm J; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1982 Jan; 112(4):120-3. PubMed ID: 7063823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.
    Reisin E; Abel R; Modan M; Silverberg DS; Eliahou HE; Modan B
    N Engl J Med; 1978 Jan; 298(1):1-6. PubMed ID: 337144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How useful is weight reduction in the management of hypertension?
    Croft PR; Brigg D; Smith S; Harrison CB; Branthwaite A; Collins MF
    J R Coll Gen Pract; 1986 Oct; 36(291):445-8. PubMed ID: 3440987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of weight reduction on blood pressure in 301 obese patients.
    Schotte DE; Stunkard AJ
    Arch Intern Med; 1990 Aug; 150(8):1701-4. PubMed ID: 2383165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of gastric bypass surgery on hypertension in morbidly obese patients.
    Carson JL; Ruddy ME; Duff AE; Holmes NJ; Cody RP; Brolin RE
    Arch Intern Med; 1994 Jan; 154(2):193-200. PubMed ID: 8285814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight reduction in obese hypertensive patients.
    Cohen MD; D'Amico FJ; Merenstein JH
    Fam Med; 1991 Jan; 23(1):25-8. PubMed ID: 2001777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term hypocaloric diet on sympatho-vagal interaction assessed by spectral analysis of heart rate and blood pressure variability during stress tests in obese hypertensive patients.
    Ashida T; Ono C; Sugiyama T
    Hypertens Res; 2007 Dec; 30(12):1199-203. PubMed ID: 18344625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension.
    Blaufox MD; Langford HG; Oberman A; Hawkins CM; Wassertheil-Smoller SW; Cutter GR
    J Hypertens Suppl; 1984 Dec; 2(3):S179-81. PubMed ID: 6599665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of reducing diet and increased leisure time physical activity on hypertension associated with obesity.
    Pecelj-Gec M; Jorga J; Rsumović S; Neradović-Mladenovski L; Zbutega-Milosević G
    Acta Med Iugosl; 1990; 44(4):367-76. PubMed ID: 2091440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between body weight and blood pressure.
    Staessen J; Fagard R; Amery A
    J Hum Hypertens; 1988 Dec; 2(4):207-17. PubMed ID: 3070038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
    Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.